Small Interfering RNA (siRNA) - Oligonucleotide Therapeutics Market Statistics
The global small interfering rna (sirna) oligonucleotide therapeutics market size was valued at US$ 2,337.8 million in 2025 and is estimated to grow at a compound annual growth rate (CAGR) of 24.2% from 2025 to 2033.
Related Statistics
Small Interfering RNA (SIRNA) - Oligonucleotide therapeutics market highlights
- The global small interfering rna (sirna) segment generated a revenue of USD 2,337.8 million in 2025 and is expected to reach USD 13,190.5 million by 2033.
- The market is expected to grow at a CAGR (2026 - 2033) of 24.2% by 2033.
- In terms of region, North America was the largest revenue generating market in 2025.
- Country-wise, Japan is expected to register the highest CAGR from 2026 to 2033.
Market summary
| Market revenue in 2025 | USD 2,337.8 million |
| Market revenue in 2033 | USD 13,190.5 million |
| Growth rate | 24.2% (CAGR from 2026 to 2033) |
| Historical data covered | 2021 - 2024 |
| Base year for estimation | 2025 |
| Forecast period covered | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Oligonucleotide Therapeutics Market Scope
Oligonucleotide therapeutics market segmentation & scope
Oligonucleotide Therapeutics Market Outlook
- HTML
- PPT
- -
Everything on Oligonucleotide Therapeutics Market Outlook in one document: edited and divided into chapters, including detailed references.
Related industry reports
Related Regional Reports
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
